CUE
Cue Biopharma, Inc.$14.01-2.02 (-12.53%)Prev Close$16.12·MCap$200.9M·P/E—·Vol181.6K·Yield—
▲
Buys (12M)
2
$599.7K
▼
Sells (12M)
6
$2.43M
◆
Net Activity
Net Seller
$1.83M
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at Cue Biopharma, Inc. (CUE) has been dominated by selling, with 2 insider purchases totaling $599.7K and 6 insider sales totaling $2.43M. The most recent insider transaction was by Ray Sumita (officer, other: Chief Legal Compliance Officer), who sold $51.7K worth of shares on Oct 14, 2026. Cue Biopharma, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $200.9M.
CUE Insider Trading Activity
CUE Insider Buying Activity
The following table shows recent insider purchases of Cue Biopharma, Inc. (CUE) stock reported via SEC Form 4 filings.
CUE Insider Selling Activity
The following table shows recent insider sales of Cue Biopharma, Inc. (CUE) stock reported via SEC Form 4 filings.